NCT06394817 Beijing Disability Risk and Ageing Monitoring Study
| NCT ID | NCT06394817 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Age Problem |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-02-20 |
| Primary Completion | 2063-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-02-20 with a primary completion date of 2063-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a community-based prospective cohort study in Beijing, China. The study has been initialized in 2023 and enrolled older residents. This study aims to develop disability risk assessment standards and an early warning model for older adults.
Eligibility Criteria
Inclusion Criteria: * Aged 60 years or older * Lived in the community for more than 1 year * Signed the informed consent form Exclusion Criteria: * Cannot complete the survey
Contact & Investigator
Yi Tang, MD., PhD
PRINCIPAL INVESTIGATOR
Xuanwu Hospital, Beijing
Frequently Asked Questions
Who can join the NCT06394817 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Age Problem. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06394817 currently recruiting?
Yes, NCT06394817 is actively recruiting participants. Contact the research team at tangyi@xwhosp.org for enrollment information.
Where is the NCT06394817 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06394817 clinical trial?
NCT06394817 is sponsored by Xuanwu Hospital, Beijing. The principal investigator is Yi Tang, MD., PhD at Xuanwu Hospital, Beijing. The trial plans to enroll 2,000 participants.